Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Zhifei Biological: Shingles mRNA Vaccine Approved for Clinical Trials
Zhifei Biological announced that its wholly-owned subsidiary Zhifei Longcom’s shingles mRNA vaccine has received the clinical trial approval notice from the National Medical Products Administration, allowing the company to conduct clinical trials for the prevention of shingles. The vaccine is an independently developed mRNA technology product with good immunogenicity and safety, capable of effectively preventing shingles. This approval will further enrich the company’s adult vaccine portfolio, improve product layout, and strengthen market position.